Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Locally-advanced Rectal Cancer × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 53 Colonic Neoplasms 30 Rectal Neoplasms 29 Pancreatic Neoplasms 29 Stomach Neoplasms 22 Neoplasm Metastasis 17 Carcinoma, Non-Small-Cell Lung 16 Neoplasms 15 Unspecified Adult Solid Tumor, Protocol Specific 14 Esophageal Neoplasms 10 Ovarian Neoplasms 7 Gallbladder Neoplasms 7 Appendiceal Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 6 Breast Neoplasms 6 Bile Duct Neoplasms 6 Peritoneal Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Liver Neoplasms 5 Gastrointestinal Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Recurrence 4 Carcinoma, Pancreatic Ductal 4 Triple Negative Breast Neoplasms 3 Solid Tumors 3 Solid Tumor 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Oxaliplatin 1 Folfox protocol 1 Capecitabine 1 ASTX-660 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting

Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡